26. Stubblefield PG, Menstüral impact of contraception Am J Obstet Gynecol 1994;170:1513-1522
27. Rozenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives; risk indicators for poor pill taking and discontunation. Contraception 1995;51:283-288
28. Archer DF, Philput CA, Weber ME. Menagement of irregular uterine bleeding and spotting associated with Norplant. Hum Reprod 1996;11(Suppl 2):24-30
29. Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000;74: 1063-1070
30. Hacker NF, Moore JG. Essentials of Obstetrics and Gynecology 3. baskı, Philadelphia: WB Saunders. 1998:635
31. Kurman, R.(ed.): Blausteins Pathology of the Female genital tract. 3rd ed. Newyork, Springer-Verlag, 1987.
32. Kumar, Cotran, Robbins: Basic Pathology 5th ed. USA, WB. Saunders 1992. 33. Berek JS. Novak Jinekoloji. In: Lurain JR, ed. Uterus kanseri. Nobel Tıp
Kitapevi, 2011;7: 1349 34. Çiçek MN, Akyürek C, Çelik Ç, Haberal A. Kadın Hastalıkları ve Dogum
Bilgisi. In: Özgünen T, ed. Korpus Uterinin Premalign-Malign Hastalıkları. Günes Kitabevi, 2006;100: 1179-2 35. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985;56: 403. 36. Lacey JV Jr, Sherman ME, Rush BB, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol 2010;28: 788. 37. Hunter JE, Tritz DE, Howell MG, et al. The prognostic and therapeutic implications of cytological atypia in patients with endometrial hyperplasia. Gynecol Oncol 1994;55: 66-71. 38. Jutras ML, Cowan BD. Abnormal bleeding in the climacteric. Obstet Gynecol Clin North Am. Jun. 1990;17(2):409-25. 39. Van Bogaert LJ. Clinicopathologicfindings inendometrial polyps. Obstet Gynecol. 1988;71: 771-773.



73. SAYFAYA BENZER SAYFALAR

Endometium kanserli hastalarda operasyon öncesi değerlendirmede PET-BT nin yeri - Sayfa 106
17. http://www. apsu.edu/thompsOnj/Anatomy. 2009-11-14. 18. Nichols DH, Pelvic anatomy of the living in vaginal surgery, 2 nd ed.1983. 1-40 19. Kaplan A, Alaittin E. Anatomi Kitabı Cilt 1. 432-434 20. Balfe DM, Peterson RR, Lee JKT. Normal abdominal anatomy. In: Lee JKT, Sagel SS; Stanley RJ (eds). Computed body tomography.1983;131-165 21. Schwalm H, Dubrauszky V. The structure of musculatuare of...
Erken evre endometrium kanserinde laparoskopik cerrahinin laparatomik cerrahi ile karşılaştırılması - Sayfa 64
20. Ziel H, and Finkle W. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975; 293:1167-70. 21. Lauritzen C. Estrogens and endometrial cancer: a point of view. Clin Obstet Gynecol 1977; 4:145-67. 22. McDonald TW, Malkasian GD, Gaffey TA. Endometrial cancer associated with feminizing ovarian tumors and polycistic ovarian disease. Obstet Gynecol. 1977; 94...
Endometriyal lezyon spektrumunda objektif risk tanımı için morfolojik ve moleküler verilerin birlikte kullanıldığı tanısal bir algoritma - Sayfa 77
105. Rosai J.: Cysts, Stromal Hyperplasia and Other Non-Neoplastic Lesions. Rosai and Ackerman's Surgical Pathology, Philadelphia, Elseiver 2004, 1653-6. 106. Rosai J. : Dysfunctional Uterine Bleeding and Hyperplasia. Rosai and Ackerman's Surgical Pathology, Philadelphia, Elseiver 2004: 1579-83. 107. Schmitz M.J. , Hendricks D.T. , Farley J., Taylor R.R., Geradts J. , Rose G.S.: P27 and Cyclin 01...

73. SAYFADAKI ANAHTAR KELIMELER

carcinoma
cancer
hyperplasia
pathology
obstet
gynecol


73. SAYFA ICERIGI

26. Stubblefield PG, Menstüral impact of contraception Am J Obstet Gynecol 1994;170:1513-1522
27. Rozenberg MJ, Waugh MS, Meehan TE. Use and misuse of oral contraceptives; risk indicators for poor pill taking and discontunation. Contraception 1995;51:283-288
28. Archer DF, Philput CA, Weber ME. Menagement of irregular uterine bleeding and spotting associated with Norplant. Hum Reprod 1996;11(Suppl 2):24-30
29. Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000;74: 1063-1070
30. Hacker NF, Moore JG. Essentials of Obstetrics and Gynecology 3. baskı, Philadelphia: WB Saunders. 1998:635
31. Kurman, R.(ed.): Blausteins Pathology of the Female genital tract. 3rd ed. Newyork, Springer-Verlag, 1987.
32. Kumar, Cotran, Robbins: Basic Pathology 5th ed. USA, WB. Saunders 1992. 33. Berek JS. Novak Jinekoloji. In: Lurain JR, ed. Uterus kanseri. Nobel Tıp
Kitapevi, 2011;7: 1349 34. Çiçek MN, Akyürek C, Çelik Ç, Haberal A. Kadın Hastalıkları ve Dogum
Bilgisi. In: Özgünen T, ed. Korpus Uterinin Premalign-Malign Hastalıkları. Günes Kitabevi, 2006;100: 1179-2 35. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985;56: 403. 36. Lacey JV Jr, Sherman ME, Rush BB, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia. J Clin Oncol 2010;28: 788. 37. Hunter JE, Tritz DE, Howell MG, et al. The prognostic and therapeutic implications of cytological atypia in patients with endometrial hyperplasia. Gynecol Oncol 1994;55: 66-71. 38. Jutras ML, Cowan BD. Abnormal bleeding in the climacteric. Obstet Gynecol Clin North Am. Jun. 1990;17(2):409-25. 39. Van Bogaert LJ. Clinicopathologicfindings inendometrial polyps. Obstet Gynecol. 1988;71: 771-773.

İlgili Kaynaklar







single.php